top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


The Enormous Impact of EVA/PCD Chemosensitivity Testing in Patients with Rare Cancers: Durable Benefit Provided by An Unexpected Recommendation
The drug we recommended, Pazopanib, would not normally be expected to have activity in this rare and aggressive cancer.

Dr. Robert A. Nagourney, MD
Nov 32 min read


STAGE 4 STOMACH CANCER: NOT A DEATH SENTENCE BUT AN OPPORTUNITY
As seen from our 48-year-old patient, now 11 years since diagnosis, the right treatment for stomach (gastric) and gastroesophageal cancer can be curative.

Dr. Robert A. Nagourney, MD
Dec 2, 20253 min read


Stage 4 Stomach Cancer: Shelly Powell
My oncologist said that the results were remarkable and that I chose the right drugs based on Dr. Nagourney's testing.

Dr. Robert A. Nagourney, MD
Mar 29, 20232 min read
bottom of page
